期刊文献+

置入冠状动脉支架患者腹腔镜胆囊切除麻醉的处理

下载PDF
导出
摘要 目的对置入冠状动脉支架患者行腹腔镜胆囊切除术的麻醉处理措施进行分析。方法行腹腔镜胆囊切除术的18例置入冠状动脉支架患者,对其麻醉方法及麻醉效果进行回顾性分析。结果所有患者均顺利完成手术治疗,均未中转开腹手术,患者平均手术时间(57.3±2.1)min,平均麻醉时间(71.4±2.3)min,术后平均苏醒时间(27.3±2.4)min;部分患者在术前、术中及气管拔管时有血压升高、心率加快现象,在给予地尔硫卓、艾司洛尔对症处理后均恢复正常。结论置入冠状动脉支架患者行腹腔镜胆囊切除术时手术风险较大,对麻醉方法有较高要求,在术前应全面评估患者身体情况并做好准备工作,严格根据要求展开麻醉处理,从而为手术治疗的顺利进行提供有力保障。
作者 刘建
出处 《中国实用医药》 2014年第24期171-172,共2页 China Practical Medicine
  • 相关文献

参考文献3

二级参考文献15

  • 1张莉莉,贾国良,王海昌,郭文怡,马兰香,孙玉波.抗血小板药物对冠心病支架植入术后再狭窄防治效果的观察[J].心脏杂志,2004,16(5):459-461. 被引量:9
  • 2杨冀萍,刘怀军,张聪敏,袁雅冬,阎锡新,吴雅莉.流式细胞术分析活化血小板及其在急性肺血栓栓塞症中的临床意义[J].临床心血管病杂志,2007,23(2):116-118. 被引量:3
  • 3SALGADO FILHO W, MARTINEZ FILHO E E,HONA P,et al. Intracoronary inflammatory markersafter percutaneous coronary interventions [ J ]. ArqBras Cardiol,2005 ,85 : 180 — 185.
  • 4PHILIPPE L L, GREGORY D, NICOLAS P, el al.Clopidogrel 600-mg double loading dose achieves strongerplatelet inhibition than conventional regimens [J]. J AmColl CardioU2008,51 :1066-1072.
  • 5KWAIJTAAL M, VAN D R,BAR F W, et al. In-flammatory markers predict late cardiac events in pa-tients who are exhausted after percutaneous coronaryintervention [ J ]. Atherosclerosis, 2005 . 182 : 341 —348.
  • 6MURASAKI K,KAWANA M,MURASAKI S, et al.High P-selectin expression and low CD36 occupancy oncirculating platelets are strong predictors of restenosis af-ter coronary stenting in patients with coronary artery dis-ease[J]. Heart Vessels.2007,22 :229 — 236.
  • 7VOLCIK K A,BALLANTYNE C M, CORESH J,et al. Specific P-selectin and P-selectin glycoproteinligand-1 genotypes/haplotypes are associated withrisk of incident CHD and ischemic stroke: the athero-sclerosis risk in communities (ARIC) study[J], Ath-erosclerosis ,2007,195 :76 — 82.
  • 8DORR G,SCHMIDT G,GRAFE M,et al. Effects ofcombined therapy with clopidogrel and acetylsalicylic acidon platelet glycoprotein expression and aggregation[J]. JCardiovasc Pharmacol,2002,39:523 — 532.
  • 9VAN DER ZEE P M, BIRO E,KO Y,et al. P-selectinand CD63 exposing platelet microparticles reflect plateletactivation in peripheral arterial disease and myocardial in-farction[J]. Clin Chem,2006,52:4657 — 664.
  • 10HIROYUKI O,SATOSHI I, SEIJI K,et al. Atorv-astatin induces associated reductions in platelet P-se-lectin. oxidized low-density lipoprotein,and interleu-kin-6 in patients with coronary artery diseases [J].Heart Vessels, 2008,23:249 — 256.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部